Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -0.534M
March 31, 2026 -18.20M
December 31, 2025 -4.73M
September 30, 2025 -0.225M
June 30, 2025 -0.293M
March 31, 2025 -0.212M
December 31, 2024 -37.56M
September 30, 2024 -0.597M
June 30, 2024 5.103M
March 31, 2024 -0.11M
December 31, 2023 -0.203M
September 30, 2023 -20.13M
June 30, 2023 -1.249M
March 31, 2023 -130.97M
December 31, 2022 -0.005M
September 30, 2022 -1.069M
June 30, 2022 -0.259M
March 31, 2022 -0.41M
December 31, 2021 -14.20M
September 30, 2021 -12.93M
June 30, 2021 8.669M
March 31, 2021 -0.224M
December 31, 2020 -0.09M
September 30, 2020 -0.281M
June 30, 2020 -0.337M
Date Value
March 31, 2020 -0.273M
December 31, 2019 -0.969M
September 30, 2019 -0.079M
June 30, 2019 -0.461M
March 31, 2019 -0.324M
December 31, 2018 -0.852M
September 30, 2018 -0.647M
June 30, 2018 -0.436M
March 31, 2018 -0.264M
December 31, 2017 -0.249M
September 30, 2017 -0.197M
June 30, 2017 -0.299M
March 31, 2017 -0.216M
December 31, 2016 -0.114M
September 30, 2016 -1.145M
June 30, 2016 -3.557M
March 31, 2016 -2.423M
December 31, 2015 -0.871M
September 30, 2015 -1.046M
June 30, 2015 -0.18M
March 31, 2015 -3.033M
December 31, 2014 -0.0821M
September 30, 2014 -0.0773M
June 30, 2014 -0.6999M
March 31, 2014 -0.0512M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Viatris, Inc. -51.60M
Zevra Therapeutics, Inc. 31.45M
Indivior Pharmaceuticals, Inc. -7.942M
Liquidia Corp. -12.24M
60 Degrees Pharmaceuticals, Inc. -0.086M